Literature DB >> 16845491

Apoptotic and proliferating hepatocytes differ in prothymosin alpha expression and cell localization.

Luciana Barbini1, Rosario Gonzalez, Fernando Dominguez, Felix Vega.   

Abstract

Prothymosin alpha is an acidic protein, reported to be involved in cell proliferation and apoptosis, although its precise function in both processes are still unknown. Due to the importance of these processes in the pathogenesis of hepatic diseases and the need to understand the molecular mechanisms underlying these diseases we aimed to investigate the behavior of this protein in liver growth and apoptosis, in two models of hepatocytes in culture. Prothymosin alpha expression varied throughout the hepatocyte cell cycle, according to its progression. Proliferating hepatocytes showed increased expression of the protein, while apoptotic ones showed decreased levels. The subcellular location of prothymosin alpha differed according to the different phases of the cell cycle. Thus, it appeared with a stippled and widely dispersed pattern throughout the nucleus in quiescent and proliferating hepatocytes, while it became cytoplasmic in mitotic and late apoptotic cells. These results are in agreement with the idea that high levels of prothymosin alpha need to be present in the nucleus for proliferation, and programmed cell death requires low levels of prothymosin alpha outside of the nucleus. The differences in prothymosin alpha expression and localization during hepatocyte proliferation and apoptosis suggest that this protein may have a pleiotropic function that depends not only on its availability but also on its various localizations in different subcellular compartments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845491     DOI: 10.1007/s11010-006-9200-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action.

Authors:  C N Conteas; M G Mutchnick; K C Palmer; F E Weller; G D Luk; P H Naylor; M R Erdos; A L Goldstein; C Panneerselvam; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Regulation of prothymosin alpha during the cell cycle.

Authors:  K Vareli; O Tsolas; M Frangou-Lazaridis
Journal:  Eur J Biochem       Date:  1996-06-15

3.  Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells.

Authors:  P Rodríguez; J E Viñuela; L Alvarez-Fernández; M Buceta; A Vidal; F Domínguez; J Gómez-Márquez
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

4.  Prothymosin alpha is a nuclear protein.

Authors:  J Gómez-Márquez; F Segade
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

Review 5.  Apoptosis in liver disease.

Authors:  M Schuchmann; P R Galle
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

6.  Prothymosin alpha expression in lymph nodes and tonsils: an optical and ultrastructural study.

Authors:  R Gallego; E Rosón; T García-Caballero; M Fraga; J Forteza; F Domínguez; A Beiras
Journal:  Acta Anat (Basel)       Date:  1992

7.  Cellular distribution of prothymosin alpha and parathymosin in rat thymus and spleen.

Authors:  E Roson; G Garcia-Caballero; E P Heimer; A M Felix; F Dominguez
Journal:  J Histochem Cytochem       Date:  1990-12       Impact factor: 2.479

8.  Prothymosin alpha promotes cell proliferation in NIH3T3 cells.

Authors:  C L Wu; A L Shiau; C S Lin
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

9.  TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth.

Authors:  C Carneiro; C V Alvarez; J Zalvide; A Vidal; F Domínguez
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

10.  Liver regeneration, liver cancers and cyclins.

Authors:  Tsuneo Kitamura; Sumio Watanabe; Nobuhiro Sato
Journal:  J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 4.029

View more
  5 in total

1.  Transgenic expression of prothymosin alpha on zebrafish epidermal cells promotes proliferation and attenuates UVB-induced apoptosis.

Authors:  Chiung-Wen Pai; Yau-Hung Chen
Journal:  Transgenic Res       Date:  2009-12-11       Impact factor: 2.788

2.  The methyl ester of okadaic acid is more potent than okadaic acid in disrupting the actin cytoskeleton and metabolism of primary cultured hepatocytes.

Authors:  Begoña Espiña; M Carmen Louzao; Eva Cagide; Amparo Alfonso; Mercedes R Vieytes; Takeshi Yasumoto; Luis M Botana
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

3.  Cytoskeletal toxicity of pectenotoxins in hepatic cells.

Authors:  B Espiña; M C Louzao; I R Ares; E Cagide; M R Vieytes; F V Vega; J A Rubiolo; C O Miles; T Suzuki; T Yasumoto; L M Botana
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

4.  Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.

Authors:  Yi-Te Lin; Chuck C-K Chao
Journal:  Oncotarget       Date:  2015-11-17

5.  Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.

Authors:  Caroline Mwendwa Kijogi; Christopher Khayeka-Wandabwa; Keita Sasaki; Yoshimasa Tanaka; Hiroshi Kurosu; Hayato Matsunaga; Hiroshi Ueda
Journal:  BMC Physiol       Date:  2016-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.